Long-term Follow-up Gene Therapy Study for RPGR- XLRP

Clinical trial NCT04312672 · COMPLETED

Trial details

NCT number: NCT04312672
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Study type: OBSERVATIONAL

X-Linked Retinitis Pigmentosa

Start date: 2017-07-31
Primary completion: 2025-09-17
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.